These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35946556)
1. GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway. Wang J; Dai W; Zhang M Anticancer Drugs; 2023 Jan; 34(1):57-72. PubMed ID: 35946556 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
3. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells. Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291 [TBL] [Abstract][Full Text] [Related]
4. [Hinokiol regulates the cell cycle and apoptosis of nasopharyngeal carcinoma CNE1 cells via Hippo-YAP signaling pathway]. Wu KY; Liu L; Wu ZH; Huang Q; Xie RJ; Zhou L; Wang M Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jun; 59(6):621-629. PubMed ID: 38965852 [No Abstract] [Full Text] [Related]
5. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656 [TBL] [Abstract][Full Text] [Related]
7. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway. Li T; Li Y Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594 [TBL] [Abstract][Full Text] [Related]
8. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342 [TBL] [Abstract][Full Text] [Related]
9. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p. Bao J; Zhang S; Meng Q; Qin T Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621 [TBL] [Abstract][Full Text] [Related]
10. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378 [TBL] [Abstract][Full Text] [Related]
11. Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis. Zhang X; Zhang J; Liu Q; Zhao Y; Zhang W; Yang H Neurochem Res; 2020 Dec; 45(12):2840-2855. PubMed ID: 33000435 [TBL] [Abstract][Full Text] [Related]
12. Tetrandrine induces apoptosis in human neuroblastoma through regulating the Hippo/YAP signaling pathway. Zhao Q; Jia X; Zhang Y; Dong Y; Lei Y; Tan X; Williamson RA; Wang A; Zhang D; Ma J Biochem Biophys Res Commun; 2019 Jun; 513(4):846-851. PubMed ID: 31003773 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway. Deng L; Zou J; Su Y; Wang M; Zhao L Clin Transl Oncol; 2022 Nov; 24(11):2210-2221. PubMed ID: 35842894 [TBL] [Abstract][Full Text] [Related]
14. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway. Xu J; Fang X; Long L; Wang S; Qian S; Lyu J Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962 [TBL] [Abstract][Full Text] [Related]
15. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Yang C; Tan J; Zhu J; Wang S; Wei G Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761 [TBL] [Abstract][Full Text] [Related]
16. E2F1 induced neuroblastoma cell migration and invasion via activation of CENPE/FOXM1 signaling pathway. Wang J; Dai W; Zhang M Int J Neurosci; 2024 May; 134(5):530-542. PubMed ID: 36168932 [No Abstract] [Full Text] [Related]
17. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146 [TBL] [Abstract][Full Text] [Related]
18. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells]. Yan R; Liang ZW; Liu HS; Ge Y; An GY Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016 [No Abstract] [Full Text] [Related]
19. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway. Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661 [TBL] [Abstract][Full Text] [Related]